MedTrace Logo

Negative Predictive Value of Drug Provocation Tests to Beta-lactams

NCT02844712 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 750

Last updated 2016-07-26

No results posted yet for this study

Summary

Patients with a complete drug allergy work-up to betalactam antibiotics were contacted (by mail) and asked to answer a questionnaire regarding the tolerance upon readministration of a negatively tested beta-lactam.

Conditions

  • Drug Hypersensitivity

Interventions

OTHER

Evaluation of reexposure to a negatively tested betalactam

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-05-31
Completion
2016-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02844712 on ClinicalTrials.gov